Advancements are happening in every corner of medicine. Brilliant
new innovations are upending traditional thinking and power
structures in the development of treatments and the delivery of
Join Carolyn Morgan in This Medical Moment and learn how others are overcoming the obstacles. She will be joined by guests who are leading critical changes in the standards of care.
What’s coming next? Find out. In a moment.
Never miss a medical moment
The most extraordinary moments in medicine are happening right now,
but will these innovations get the opportunity to change lives?
Stay in the know and be the first to watch new episodes of This Medical Moment.
Thank you for signing up!
Have a minute to give a moment?
We’re running this work break series to share ideas that may inspire you as you take the next medical breakthrough to market. Chances are, you surround yourself with people just as curious as you. Please pass this on!
Each month, Carolyn speaks with the innovators-of-the-moment revealing the twists and trials involved in moving medicine forward. This quick, work-break series explores what drives individuals to take on the status quo and just what barriers lie on the path to wide-scale adoption.
Episode 3 - Out-of-the-Box Cancer Screening
Each year, 110 million people worldwide should be screened for
colon cancer. Despite this staggering statistic, an estimated 45
million people avoid it annually. Exact Sciences is helping to
change this narrative with their novel at-home cancer screening
kit, Cologuard, and they're finding profound success.
How did Exact Sciences overcome commercial barriers to change the standard of care in colon cancer screening? What lessons can be learned for other aspiring healthcare entrepreneurs? Exact Sciences' CEO Kevin Conroy shares the success story of Cologuard.
Episode 2 - Speed Reading the Brain
Is it Parkinson's Disease or Essential Tremor? For the 10 million
people in the United States living with a tremor disorder, they'll
need brain imaging for proper diagnosis. But, there are issues
with today's imaging technology—it is time consuming (think
hours). Likeminds developed an agent that can get you the same
reading, in minutes.
How does this imaging agent impact healthcare costs? What are the patient benefits? Which diseases do we hope to get earlier diagnosis for? Likeminds CEO Peter Savas shares the future of brain imaging.
Episode 1 - Facial Recognition in Rare
On average, a patient with a rare disease takes 4.8 years to find
a correct diagnosis. For patients and families searching for
answers, this wait can be agonizing. FDNA's Face2Gene technology
is helping to change the standard of care and shorten the time to
diagnosis - all through the use of a smartphone.
How did this novel tool come to be? What was the path to adoption like? FDNA former CEO Dekel Gelbman shares his team's story and the impact they hope to leave on the medical world.